XML 27 R6.htm IDEA: XBRL DOCUMENT v3.25.3
CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY - USD ($)
Ordinary shares
Class A Ordinary Shares
Ordinary shares
Class B Ordinary Share
Ordinary shares
Additional paid-in capital
Accumulated deficit
Noncontrolling interests
Total
Balance at the beginning at Jun. 30, 2022 $ 0 $ 0 $ 918,573 $ 69,719,807 $ (35,983,424)   $ 34,654,956
Balance at the beginning (in shares) at Jun. 30, 2022     3,061,910        
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Issuance of ordinary shares for equipment purchase 0 0 $ 86,856 3,023,144 0   3,110,000
Issuance of ordinary shares for equipment purchase (in shares)     289,520        
Issuance of ordinary shares for compensation 0 0 $ 3,951 63,320 0   67,271
Issuance of ordinary shares for compensation (in shares)     13,169        
Warrants issued with convertible debenture 0 0 $ 0 645,196 0   645,196
Additional ordinary shares of round-up adjustment for reverse share split 0 0 $ 4,948 (4,948) 0   0
Additional ordinary shares of round-up adjustment for reverse share split (in shares)     16,493        
Net loss 0 0 $ 0   (28,216,352)   (28,216,352)
Balance at the end at Jun. 30, 2023 0 0 $ 1,014,328 73,446,519 (64,199,776)   10,261,071
Balance at the end (in shares) at Jun. 30, 2023     3,381,092        
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Sales of ordinary shares 0 0 $ 843,850 3,150,372 0   3,994,222
Sales of ordinary shares (in shares)     2,812,833        
Issuance of ordinary shares for compensation 0 0 $ 10,272 62,958 0   73,230
Issuance of ordinary shares for compensation (in shares)     34,240        
Warrants issued with convertible debenture 0 0 $ 0 2,560,858 0   2,560,858
Conversion convertible debenture into ordinary shares 0 0 $ 204,055 1,020,271 0   1,224,326
Conversion convertible debenture into ordinary shares (in shares)     680,183        
Exercise of warrants 0 0 $ 255,000 896,903 0   1,151,903
Exercise of warrants (in shares)     850,000        
Exchange of warrants for convertible debenture 0 0 $ 0 (71,319) 0   (71,319)
Noncontrolling interests acquired 0 0 0   0 $ 250 250
Net loss 0 0 0   (17,531,647) (753,311) (18,284,958)
Balance at the end at Jun. 30, 2024 0 0 $ 2,327,505 81,066,562 (81,731,423) (753,061) 909,583
Balance at the end (in shares) at Jun. 30, 2024     7,758,348        
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Fair value of noncontrolling interest acquired 0 0 $ 0   0 250 250
Re-designation of authorized ordinary shares $ 2,097,105 $ 230,400 $ (2,327,505)   0   0
Re-designation of authorized ordinary shares (In shares) 6,990,348 768,000 (7,758,348)        
Conversion convertible debenture into ordinary shares $ 12,779,468 $ 0 $ 0 (6,154,788) 0   6,624,680
Conversion convertible debenture into ordinary shares (in shares) 42,598,231            
Exercise of warrants $ 2,586,760 0 0 (2,586,760) 0   0
Exercise of warrants (in shares) 8,622,532            
Deemed dividend attributable to down round feature of warrants $ 0 0 0 2,146,795 (2,146,795)   0
Net loss 0 0 0   (4,387,192) 17,286 (4,369,906)
Balance at the end at Jun. 30, 2025 $ 17,463,333 $ 230,400 $ 0 $ 74,471,809 $ (88,265,410) $ (735,775) $ 3,164,357
Balance at the end (in shares) at Jun. 30, 2025 58,211,111 768,000